Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complexation Equilibria: Factors Influencing Stability of Complexes01:09

Complexation Equilibria: Factors Influencing Stability of Complexes

985
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
985
Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

1.7K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.7K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

19.2K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
19.2K
EDTA: Chemistry and Properties01:22

EDTA: Chemistry and Properties

4.0K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
4.0K
Formation of Complex Ions03:45

Formation of Complex Ions

18.8K
A type of Lewis acid-base chemistry involves the formation of a complex ion (or a coordination complex) comprising a central atom, typically a transition metal cation, surrounded by ions or molecules called ligands. These ligands can be neutral molecules like H2O or NH3, or ions such as CN− or OH−. Often, the ligands act as Lewis bases, donating a pair of electrons to the central atom. These types of Lewis acid-base reactions are examples of a broad subdiscipline called coordination...
18.8K
Complexometric Titration: Ligands00:43

Complexometric Titration: Ligands

2.4K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isoselenocyanates with Sterically Encumbered Substituents─Synthesis, Structures, and Spectroscopic Properties.

Inorganic chemistry·2026
Same author

Examination of Coligands in Mefloquine-Metal Complexes Reveals the Structural Determinants of Activity against <i>Plasmodium falciparum</i> and <i>Schistosoma mansoni</i>.

Journal of medicinal chemistry·2026
Same author

Cyclopentadienyl Complexes of Technetium.

Molecules (Basel, Switzerland)·2025
Same author

Pharmaceutical Applications of Metal Complexes and Derived Materials.

Pharmaceutics·2025
Same author

Thionitrosyl Complexes of Technetium and Rhenium with Sterically Encumbered <i>m</i>‑Terphenyl IsocyanidesSteric Bulk Matters.

Organometallics·2025
Same author

Cadmium(II) complexes with pyridine/dicarboxylic acid ligands as promising molecules for the treatment of oral candidiasis.

Journal of inorganic biochemistry·2025

Related Experiment Video

Updated: Apr 21, 2026

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII
08:26

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII

Published on: August 31, 2018

6.4K

Gold(III) complexes in medicinal chemistry.

Pedro Ivo da Silva Maia1, Victor M Deflon, Ulrich Abram

  • 1Universidade Federal do Triângulo Mineiro, Instituto de Ciências Exatas Naturais e Educação, Av. Dr. Randolfo Borges Júnior, 1400, Univerdecidade, 38064-200 Uberaba, MG, Brazil.

Future Medicinal Chemistry
|November 4, 2014
PubMed
Summary

New gold(III) compounds show potent anticancer activity, targeting mitochondria rather than DNA. These promising agents offer alternatives to platinum drugs and potential for treating other diseases.

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

12.3K
IridiumIII Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II
12:52

IridiumIII Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II

Published on: July 7, 2015

11.2K

Related Experiment Videos

Last Updated: Apr 21, 2026

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII
08:26

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII

Published on: August 31, 2018

6.4K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

12.3K
IridiumIII Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II
12:52

IridiumIII Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II

Published on: July 7, 2015

11.2K

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Pharmacology

Background:

  • Platinum-based drugs are mainstays in cancer treatment but face limitations like resistance and toxicity.
  • Gold(III) compounds present a novel therapeutic avenue with distinct mechanisms of action.
  • Developing new anticancer agents is crucial to overcome drug resistance and improve patient outcomes.

Purpose of the Study:

  • To design and evaluate gold(III) compounds as potential anticancer agents.
  • To investigate the antiproliferative effects of gold(III) compounds against various cancer cell lines, including cisplatin-resistant ones.
  • To explore the potential of gold(III) compounds beyond cancer therapy, including infectious diseases and radiotherapy.

Main Methods:

  • Synthesis and characterization of novel gold(III) compounds.
  • In vitro antiproliferative assays against a panel of cancer cell lines.
  • Investigation of cellular targets and mechanisms of action, with a focus on mitochondria.

Main Results:

  • Several gold(III) compounds demonstrated significant antiproliferative activity.
  • Efficacy was observed against cisplatin-resistant cancer cell lines, suggesting a different mechanism of action.
  • Mitochondria were identified as a primary cellular target for many of these gold compounds.

Conclusions:

  • Gold(III) compounds represent a promising class of anticancer drugs with potential to overcome platinum resistance.
  • Their unique mitochondrial-targeting mechanism offers a new strategy in cancer chemotherapy.
  • Further research into gold(III) compounds may lead to applications in treating viral/parasitic diseases and in radiotherapy.